About Novalek Pharmaceuticals
Novalek Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2006. Pharmaceutical development, production, and marketing of generic and branded drugs in India. Its Indian entity Novalek Pharmaceutical Private Limited reported revenue of ₹9.1 Lakh. Novalek Pharmaceuticals offers products and services including Oncology Products and Contrast Media. Its focus areas include Pharmaceuticals, Drug Development, Oncology and Cancer Treatments.
Company details
Novalek Pharmaceuticals Pvt. Ltd. is recognized as a Hyderabad-based entity that specializes in the development, production, and marketing of generic and proprietary branded pharmaceuticals. The company was established in 2006 in New Delhi and has since established a strong presence in the industry, focusing on segments like oncology and contrast media. Operations are managed through various international business channels, with infrastructure supporting manufacturing and distribution. Contact details are provided for enquiries, reflecting a structured approach to global outreach. All aspects are handled with a commitment to industry standards.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Website novalekpharma.com
- Legal Name Novalek Pharmaceutical Private Limited
- Date of Incorporation 09 Jan, 2006
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹9.1 Lakh
FY 2025
- Net Profit₹4.6 Lakh
FY 2025 · 50% margin
- EBITDA₹4.6 Lakh
FY 2025 · 51% margin
Associated legal entities of Novalek Pharmaceuticals
Novalek Pharmaceuticals operates through Novalek Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novalek Pharmaceutical Private Limited CIN U24231TG2006PTC120839 | Active | 09 Jan 2006 | Hyderabad, Telangana | ₹0.1 Cr | 4 | View details |
Products & Services of Novalek Pharmaceuticals
Novalek Pharmaceuticals offers a comprehensive portfolio of products and services, including Oncology Products and Contrast Media.
Oncology products are developed and marketed for cancer treatments
Contrast media are produced for diagnostic purposes in medical procedures
Board of directors of Novalek Pharmaceutical Private Limited (Novalek Pharmaceuticals)
Novalek Pharmaceutical Private Limited is the primary company behind Novalek Pharmaceuticals. The board of Novalek Pharmaceutical Private Limited currently have 4 directors; the longest-serving is Sanjay Kumar Prabhakar, appointed in 2006. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Kumar Prabhakar DIN 01672248 | Director | 09 Jan 2006 | 20 yrs 10 mo | Novalek Pharmaceutical Private Limited |
| Anu Kumari DIN 01735392 | Director | 09 Jan 2006 | 20 yrs 10 mo | Novalek Pharmaceutical Private Limited |
| Jyoti Loomba DIN 01995989 | Director | 01 Oct 2012 | 14 yrs 1 mo | Novalek Pharmaceutical Private Limited |
| Shashi Shanker Parsad Singh DIN 01993687 | Director | 01 Oct 2012 | 14 yrs 1 mo | Novalek Pharmaceutical Private Limited |
Financials of Novalek Pharmaceuticals
Figures of Novalek Pharmaceutical Private Limited, the primary company behind Novalek Pharmaceuticals, for FY 2025. Revenue was ₹9.1 Lakh. Net profit was ₹4.6 Lakh (50% margin). EBITDA was ₹4.6 Lakh (51% margin).
- ₹9.1 LakhRevenue · FY 2025
- ₹4.6 LakhNet profit · 50% margin
- ₹4.6 LakhEBITDA · 51% margin
- ₹5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Novalek Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Novalek Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Novalek Pharmaceuticals
Novalek Pharmaceuticals was founded in 2006.
Novalek Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Novalek Pharmaceuticals, Novalek Pharmaceutical Private Limited, reported revenue of ₹9.1 Lakh for FY 2025.
Novalek Pharmaceuticals Pvt. Ltd. is recognized as a Hyderabad-based entity that specializes in the development, production, and marketing of generic and proprietary branded pharmaceuticals. The company was established in 2006 in New Delhi and has since established a strong presence in the industry, focusing on segments like oncology and contrast media. Operations are managed through various international business channels, with infrastructure supporting manufacturing and distribution. Contact details are provided for enquiries, reflecting a structured approach to global outreach. All aspects are handled with a commitment to industry standards.
Novalek Pharmaceuticals offers Oncology Products and Contrast Media.
Novalek Pharmaceuticals operates through Novalek Pharmaceutical Private Limited.
The legal entities of Novalek Pharmaceuticals currently have 4 directors, including Jyoti Loomba, Sanjay Kumar Prabhakar, Shashi Shanker Parsad Singh and others.